Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

• Renske Altena,

  Affiliation Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

  ⨯
• Rudolf S. N. Fehrmann,

  Affiliations Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands, Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

  ⨯
• Hink Boer,

  Affiliation Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

  ⨯
• Elisabeth G. E. de Vries,

  Affiliation Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

  ⨯
• Coby Meijer,

  Affiliation Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

  ⨯
• Jourik A. Gietema

  * E-mail: j.a.gietema@umcg.nl

  Affiliation Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands

  ⨯